{"id":"https://openalex.org/W4408735236","doi":"https://doi.org/10.1016/j.jtct.2025.03.012","title":"Comparative Efficacy of Bendamustine Versus Fludarabine/Cyclophosphamide for Lymphodepletion Before Chimeric Antigen Receptor T-Cell Therapy in Lymphoma","display_name":"Comparative Efficacy of Bendamustine Versus Fludarabine/Cyclophosphamide for Lymphodepletion Before Chimeric Antigen Receptor T-Cell Therapy in Lymphoma","publication_year":2025,"publication_date":"2025-03-22","ids":{"openalex":"https://openalex.org/W4408735236","doi":"https://doi.org/10.1016/j.jtct.2025.03.012","pmid":"https://pubmed.ncbi.nlm.nih.gov/40122282"},"language":"en","primary_location":{"id":"doi:10.1016/j.jtct.2025.03.012","doi":"https://doi.org/10.1016/j.jtct.2025.03.012","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jtct.2025.03.012","pdf_url":null,"source":{"id":"https://openalex.org/S59987174","display_name":"Transplantation and Cellular Therapy","issn_l":"1083-8791","issn":["1083-8791","1523-6536","2666-6367"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Transplantation and Cellular Therapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/j.jtct.2025.03.012","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111754409","display_name":"Uttam K. Rao","orcid":"https://orcid.org/0000-0002-2427-3076","observed_orcids":["https://orcid.org/0000-0002-2427-3076"]},"institutions":[{"id":"https://openalex.org/I4210120128","display_name":"St David's Medical Center","ror":"https://ror.org/02v5mzt02","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210120128"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Uttam K. Rao","raw_affiliation_strings":["Sarah Cannon Transplant and Cellular Therapy Network, St. David's South Austin Medical Center, Austin, Texas. Electronic address: uttam.rao@hcahealthcare.com","Sarah Cannon Transplant and Cellular Therapy Program at St. David's South Austin Medical Center, Austin, TX. Electronic address: uttam.rao@hcahealthcare.com"],"raw_orcid":"https://orcid.org/0000-0002-2427-3076","affiliations":[{"raw_affiliation_string":"Sarah Cannon Transplant and Cellular Therapy Network, St. David's South Austin Medical Center, Austin, Texas. Electronic address: uttam.rao@hcahealthcare.com","institution_ids":["https://openalex.org/I4210120128"]},{"raw_affiliation_string":"Sarah Cannon Transplant and Cellular Therapy Program at St. David's South Austin Medical Center, Austin, TX. Electronic address: uttam.rao@hcahealthcare.com","institution_ids":["https://openalex.org/I4210120128"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019494133","display_name":"Navneet S. Majhail","orcid":"https://orcid.org/0000-0001-7082-891X","observed_orcids":["https://orcid.org/0000-0001-7082-891X"]},"institutions":[{"id":"https://openalex.org/I4210088104","display_name":"Centennial Medical Center","ror":"https://ror.org/001be0c19","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210088104"]},{"id":"https://openalex.org/I4210100810","display_name":"Sarah Cannon","ror":"https://ror.org/014t21j89","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100810"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Navneet S. Majhail","raw_affiliation_strings":["Sarah Cannon Transplant and Cellular Therapy Network, TriStar Centennial Medical Center, Nashville, Tennessee","Sarah Cannon Transplant and Cellular Therapy Network, Nashville, TN; Sarah Cannon Transplant and Cellular Therapy Program at TriStar Centennial Medical Center, Nashville, TN"],"raw_orcid":"https://orcid.org/0000-0001-7082-891X","affiliations":[{"raw_affiliation_string":"Sarah Cannon Transplant and Cellular Therapy Network, TriStar Centennial Medical Center, Nashville, Tennessee","institution_ids":["https://openalex.org/I4210088104","https://openalex.org/I4210100810"]},{"raw_affiliation_string":"Sarah Cannon Transplant and Cellular Therapy Network, Nashville, TN; Sarah Cannon Transplant and Cellular Therapy Program at TriStar Centennial Medical Center, Nashville, TN","institution_ids":["https://openalex.org/I4210088104","https://openalex.org/I4210100810"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056111361","display_name":"Betsy Blunk","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088104","display_name":"Centennial Medical Center","ror":"https://ror.org/001be0c19","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210088104"]},{"id":"https://openalex.org/I4210100810","display_name":"Sarah Cannon","ror":"https://ror.org/014t21j89","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100810"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Betsy Blunk","raw_affiliation_strings":["Sarah Cannon Transplant and Cellular Therapy Network, TriStar Centennial Medical Center, Nashville, Tennessee","Sarah Cannon Transplant and Cellular Therapy Network, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sarah Cannon Transplant and Cellular Therapy Network, TriStar Centennial Medical Center, Nashville, Tennessee","institution_ids":["https://openalex.org/I4210088104","https://openalex.org/I4210100810"]},{"raw_affiliation_string":"Sarah Cannon Transplant and Cellular Therapy Network, Nashville, TN","institution_ids":["https://openalex.org/I4210100810"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071013667","display_name":"Karin M Abernathy","orcid":"https://orcid.org/0000-0002-5669-1803","observed_orcids":["https://orcid.org/0000-0002-5669-1803"]},"institutions":[{"id":"https://openalex.org/I4210088104","display_name":"Centennial Medical Center","ror":"https://ror.org/001be0c19","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210088104"]},{"id":"https://openalex.org/I4210100810","display_name":"Sarah Cannon","ror":"https://ror.org/014t21j89","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100810"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karin Abernathy","raw_affiliation_strings":["Sarah Cannon Transplant and Cellular Therapy Network, TriStar Centennial Medical Center, Nashville, Tennessee","Sarah Cannon Transplant and Cellular Therapy Program at TriStar Centennial Medical Center, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sarah Cannon Transplant and Cellular Therapy Network, TriStar Centennial Medical Center, Nashville, Tennessee","institution_ids":["https://openalex.org/I4210088104","https://openalex.org/I4210100810"]},{"raw_affiliation_string":"Sarah Cannon Transplant and Cellular Therapy Program at TriStar Centennial Medical Center, Nashville, TN","institution_ids":["https://openalex.org/I4210088104","https://openalex.org/I4210100810"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026503525","display_name":"Carlos R. Bachier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101244","display_name":"Methodist Healthcare","ror":"https://ror.org/016d8zs37","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210101244"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carlos Bachier","raw_affiliation_strings":["Sarah Cannon Transplant and Cellular Therapy Network, Methodist Hospital, San Antonio, Texas","Sarah Cannon Transplant and Cellular Therapy Program at Methodist Hospital, San Antonio, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sarah Cannon Transplant and Cellular Therapy Network, Methodist Hospital, San Antonio, Texas","institution_ids":["https://openalex.org/I4210101244"]},{"raw_affiliation_string":"Sarah Cannon Transplant and Cellular Therapy Program at Methodist Hospital, San Antonio, TX","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111366460","display_name":"Vikas Bhushan","orcid":"https://orcid.org/0009-0007-7094-8517","observed_orcids":["https://orcid.org/0009-0007-7094-8517"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vikas Bhushan","raw_affiliation_strings":["Sarah Cannon and Texas Oncology Transplant and Cellular Therapy Network, Medical City Dallas, Dallas, Texas","Sarah Cannon and Texas Oncology Transplant and Cellular Therapy Program at Medical City Dallas, Dallas, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sarah Cannon and Texas Oncology Transplant and Cellular Therapy Network, Medical City Dallas, Dallas, Texas","institution_ids":[]},{"raw_affiliation_string":"Sarah Cannon and Texas Oncology Transplant and Cellular Therapy Program at Medical City Dallas, Dallas, TX","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103109739","display_name":"Jose Carlos Cruz","orcid":"https://orcid.org/0000-0002-2923-675X","observed_orcids":["https://orcid.org/0000-0002-2923-675X"]},"institutions":[{"id":"https://openalex.org/I4210101244","display_name":"Methodist Healthcare","ror":"https://ror.org/016d8zs37","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210101244"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jose Carlos Cruz","raw_affiliation_strings":["Sarah Cannon Transplant and Cellular Therapy Network, Methodist Hospital, San Antonio, Texas","Sarah Cannon Transplant and Cellular Therapy Program at Methodist Hospital, San Antonio, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sarah Cannon Transplant and Cellular Therapy Network, Methodist Hospital, San Antonio, Texas","institution_ids":["https://openalex.org/I4210101244"]},{"raw_affiliation_string":"Sarah Cannon Transplant and Cellular Therapy Program at Methodist Hospital, San Antonio, TX","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043371743","display_name":"Mohammed M. Elayan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088104","display_name":"Centennial Medical Center","ror":"https://ror.org/001be0c19","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210088104"]},{"id":"https://openalex.org/I4210100810","display_name":"Sarah Cannon","ror":"https://ror.org/014t21j89","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100810"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mohammed Elayan","raw_affiliation_strings":["Sarah Cannon Transplant and Cellular Therapy Network, TriStar Centennial Medical Center, Nashville, Tennessee","Sarah Cannon Transplant and Cellular Therapy Network, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sarah Cannon Transplant and Cellular Therapy Network, TriStar Centennial Medical Center, Nashville, Tennessee","institution_ids":["https://openalex.org/I4210088104","https://openalex.org/I4210100810"]},{"raw_affiliation_string":"Sarah Cannon Transplant and Cellular Therapy Network, Nashville, TN","institution_ids":["https://openalex.org/I4210100810"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048072488","display_name":"Tara K Gregory","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134093","display_name":"Colorado Blood Cancer Institute","ror":"https://ror.org/040pncp85","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134093"]},{"id":"https://openalex.org/I4210146389","display_name":"Presbyterian St. Luke's Medical Center","ror":"https://ror.org/04gka6q50","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210146389"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tara Gregory","raw_affiliation_strings":["Sarah Cannon Transplant and Cellular Therapy Network, Presbyterian/St Luke's Medical Center, Denver, Colorado; Colorado Blood Cancer Institute, Denver, Colorado","Sarah Cannon Transplant and Cellular Therapy Program at Presbyterian/St Luke's Medical Center, Denver, CO; Colorado Blood Cancer Institute, Denver, CO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sarah Cannon Transplant and Cellular Therapy Network, Presbyterian/St Luke's Medical Center, Denver, Colorado; Colorado Blood Cancer Institute, Denver, Colorado","institution_ids":["https://openalex.org/I4210134093","https://openalex.org/I4210146389"]},{"raw_affiliation_string":"Sarah Cannon Transplant and Cellular Therapy Program at Presbyterian/St Luke's Medical Center, Denver, CO; Colorado Blood Cancer Institute, Denver, CO","institution_ids":["https://openalex.org/I4210134093","https://openalex.org/I4210146389"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087810873","display_name":"Charles F. LeMaistre","orcid":"https://orcid.org/0000-0003-2462-0186","observed_orcids":["https://orcid.org/0000-0003-2462-0186"]},"institutions":[{"id":"https://openalex.org/I4210088104","display_name":"Centennial Medical Center","ror":"https://ror.org/001be0c19","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210088104"]},{"id":"https://openalex.org/I4210100810","display_name":"Sarah Cannon","ror":"https://ror.org/014t21j89","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100810"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charles F. LeMaistre","raw_affiliation_strings":["Sarah Cannon Transplant and Cellular Therapy Network, TriStar Centennial Medical Center, Nashville, Tennessee","Sarah Cannon Transplant and Cellular Therapy Network, Nashville, TN"],"raw_orcid":"https://orcid.org/0000-0003-2462-0186","affiliations":[{"raw_affiliation_string":"Sarah Cannon Transplant and Cellular Therapy Network, TriStar Centennial Medical Center, Nashville, Tennessee","institution_ids":["https://openalex.org/I4210088104","https://openalex.org/I4210100810"]},{"raw_affiliation_string":"Sarah Cannon Transplant and Cellular Therapy Network, Nashville, TN","institution_ids":["https://openalex.org/I4210100810"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103740902","display_name":"Shahbaz Ali Malik","orcid":"https://orcid.org/0000-0001-9435-3285","observed_orcids":["https://orcid.org/0000-0001-9435-3285"]},"institutions":[{"id":"https://openalex.org/I4210120128","display_name":"St David's Medical Center","ror":"https://ror.org/02v5mzt02","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210120128"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shahbaz A. Malik","raw_affiliation_strings":["Sarah Cannon Transplant and Cellular Therapy Network, St. David's South Austin Medical Center, Austin, Texas","Sarah Cannon Transplant and Cellular Therapy Program at St. David's South Austin Medical Center, Austin, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sarah Cannon Transplant and Cellular Therapy Network, St. David's South Austin Medical Center, Austin, Texas","institution_ids":["https://openalex.org/I4210120128"]},{"raw_affiliation_string":"Sarah Cannon Transplant and Cellular Therapy Program at St. David's South Austin Medical Center, Austin, TX","institution_ids":["https://openalex.org/I4210120128"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016003892","display_name":"Casey G Martin","orcid":"https://orcid.org/0000-0003-3722-3147","observed_orcids":["https://orcid.org/0000-0003-3722-3147"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Casey Martin","raw_affiliation_strings":["Genospace, Boston, Massachusetts","Genospace, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genospace, Boston, Massachusetts","institution_ids":[]},{"raw_affiliation_string":"Genospace, Boston, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086921915","display_name":"Meredith Mattlin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Meredith Mattlin","raw_affiliation_strings":["Genospace, Boston, Massachusetts","Genospace, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genospace, Boston, Massachusetts","institution_ids":[]},{"raw_affiliation_string":"Genospace, Boston, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5093880241","display_name":"Gabrielle Blade","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gabrielle Blade","raw_affiliation_strings":["Genospace, Boston, Massachusetts","Genospace, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genospace, Boston, Massachusetts","institution_ids":[]},{"raw_affiliation_string":"Genospace, Boston, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111656515","display_name":"Michael B. Maris","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134093","display_name":"Colorado Blood Cancer Institute","ror":"https://ror.org/040pncp85","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134093"]},{"id":"https://openalex.org/I4210146389","display_name":"Presbyterian St. Luke's Medical Center","ror":"https://ror.org/04gka6q50","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210146389"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael B. Maris","raw_affiliation_strings":["Sarah Cannon Transplant and Cellular Therapy Network, Presbyterian/St Luke's Medical Center, Denver, Colorado; Colorado Blood Cancer Institute, Denver, Colorado","Sarah Cannon Transplant and Cellular Therapy Program at Presbyterian/St Luke's Medical Center, Denver, CO; Colorado Blood Cancer Institute, Denver, CO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sarah Cannon Transplant and Cellular Therapy Network, Presbyterian/St Luke's Medical Center, Denver, Colorado; Colorado Blood Cancer Institute, Denver, Colorado","institution_ids":["https://openalex.org/I4210134093","https://openalex.org/I4210146389"]},{"raw_affiliation_string":"Sarah Cannon Transplant and Cellular Therapy Program at Presbyterian/St Luke's Medical Center, Denver, CO; Colorado Blood Cancer Institute, Denver, CO","institution_ids":["https://openalex.org/I4210134093","https://openalex.org/I4210146389"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059724538","display_name":"John Abraham Mathews","orcid":"https://orcid.org/0000-0003-4537-6143","observed_orcids":["https://orcid.org/0000-0003-4537-6143"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John Mathews","raw_affiliation_strings":["Sarah Cannon and Texas Oncology Transplant and Cellular Therapy Network, Medical City Dallas, Dallas, Texas","Sarah Cannon and Texas Oncology Transplant and Cellular Therapy Program at Medical City Dallas, Dallas, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sarah Cannon and Texas Oncology Transplant and Cellular Therapy Network, Medical City Dallas, Dallas, Texas","institution_ids":[]},{"raw_affiliation_string":"Sarah Cannon and Texas Oncology Transplant and Cellular Therapy Program at Medical City Dallas, Dallas, TX","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033766196","display_name":"Luke J. Mountjoy","orcid":"https://orcid.org/0000-0001-5140-8346","observed_orcids":["https://orcid.org/0000-0001-5140-8346"]},"institutions":[{"id":"https://openalex.org/I4210134093","display_name":"Colorado Blood Cancer Institute","ror":"https://ror.org/040pncp85","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134093"]},{"id":"https://openalex.org/I4210146389","display_name":"Presbyterian St. Luke's Medical Center","ror":"https://ror.org/04gka6q50","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210146389"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Luke Mountjoy","raw_affiliation_strings":["Sarah Cannon Transplant and Cellular Therapy Network, Presbyterian/St Luke's Medical Center, Denver, Colorado; Colorado Blood Cancer Institute, Denver, Colorado","Sarah Cannon Transplant and Cellular Therapy Program at Presbyterian/St Luke's Medical Center, Denver, CO; Colorado Blood Cancer Institute, Denver, CO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sarah Cannon Transplant and Cellular Therapy Network, Presbyterian/St Luke's Medical Center, Denver, Colorado; Colorado Blood Cancer Institute, Denver, Colorado","institution_ids":["https://openalex.org/I4210134093","https://openalex.org/I4210146389"]},{"raw_affiliation_string":"Sarah Cannon Transplant and Cellular Therapy Program at Presbyterian/St Luke's Medical Center, Denver, CO; Colorado Blood Cancer Institute, Denver, CO","institution_ids":["https://openalex.org/I4210134093","https://openalex.org/I4210146389"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072164039","display_name":"Jeremy Mark Pantin","orcid":"https://orcid.org/0000-0001-7536-0623","observed_orcids":["https://orcid.org/0000-0001-7536-0623"]},"institutions":[{"id":"https://openalex.org/I4210088104","display_name":"Centennial Medical Center","ror":"https://ror.org/001be0c19","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210088104"]},{"id":"https://openalex.org/I4210100810","display_name":"Sarah Cannon","ror":"https://ror.org/014t21j89","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100810"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeremy M. Pantin","raw_affiliation_strings":["Sarah Cannon Transplant and Cellular Therapy Network, TriStar Centennial Medical Center, Nashville, Tennessee","Sarah Cannon Transplant and Cellular Therapy Program at TriStar Centennial Medical Center, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sarah Cannon Transplant and Cellular Therapy Network, TriStar Centennial Medical Center, Nashville, Tennessee","institution_ids":["https://openalex.org/I4210088104","https://openalex.org/I4210100810"]},{"raw_affiliation_string":"Sarah Cannon Transplant and Cellular Therapy Program at TriStar Centennial Medical Center, Nashville, TN","institution_ids":["https://openalex.org/I4210088104","https://openalex.org/I4210100810"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Aravind Ramakrishnan","orcid":"https://orcid.org/0009-0009-4629-4941","observed_orcids":["https://orcid.org/0009-0009-4629-4941"]},"institutions":[{"id":"https://openalex.org/I4210120128","display_name":"St David's Medical Center","ror":"https://ror.org/02v5mzt02","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210120128"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aravind Ramakrishnan","raw_affiliation_strings":["Sarah Cannon Transplant and Cellular Therapy Network, St. David's South Austin Medical Center, Austin, Texas","Sarah Cannon Transplant and Cellular Therapy Program at St. David's South Austin Medical Center, Austin, TX"],"raw_orcid":"https://orcid.org/0009-0009-4629-4941","affiliations":[{"raw_affiliation_string":"Sarah Cannon Transplant and Cellular Therapy Network, St. David's South Austin Medical Center, Austin, Texas","institution_ids":["https://openalex.org/I4210120128"]},{"raw_affiliation_string":"Sarah Cannon Transplant and Cellular Therapy Program at St. David's South Austin Medical Center, Austin, TX","institution_ids":["https://openalex.org/I4210120128"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014618029","display_name":"Paul J. Shaughnessy","orcid":"https://orcid.org/0000-0003-4023-3864","observed_orcids":["https://orcid.org/0000-0003-4023-3864"]},"institutions":[{"id":"https://openalex.org/I4210101244","display_name":"Methodist Healthcare","ror":"https://ror.org/016d8zs37","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210101244"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul Shaughnessy","raw_affiliation_strings":["Sarah Cannon Transplant and Cellular Therapy Network, Methodist Hospital, San Antonio, Texas","Sarah Cannon Transplant and Cellular Therapy Program at Methodist Hospital, San Antonio, TX"],"raw_orcid":"https://orcid.org/0000-0003-4023-3864","affiliations":[{"raw_affiliation_string":"Sarah Cannon Transplant and Cellular Therapy Network, Methodist Hospital, San Antonio, Texas","institution_ids":["https://openalex.org/I4210101244"]},{"raw_affiliation_string":"Sarah Cannon Transplant and Cellular Therapy Program at Methodist Hospital, San Antonio, TX","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058757098","display_name":"Michael Timothy Tees","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134093","display_name":"Colorado Blood Cancer Institute","ror":"https://ror.org/040pncp85","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134093"]},{"id":"https://openalex.org/I4210146389","display_name":"Presbyterian St. Luke's Medical Center","ror":"https://ror.org/04gka6q50","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210146389"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael T. Tees","raw_affiliation_strings":["Sarah Cannon Transplant and Cellular Therapy Network, Presbyterian/St Luke's Medical Center, Denver, Colorado; Colorado Blood Cancer Institute, Denver, Colorado","Sarah Cannon Transplant and Cellular Therapy Program at Presbyterian/St Luke's Medical Center, Denver, CO; Colorado Blood Cancer Institute, Denver, CO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sarah Cannon Transplant and Cellular Therapy Network, Presbyterian/St Luke's Medical Center, Denver, Colorado; Colorado Blood Cancer Institute, Denver, Colorado","institution_ids":["https://openalex.org/I4210134093","https://openalex.org/I4210146389"]},{"raw_affiliation_string":"Sarah Cannon Transplant and Cellular Therapy Program at Presbyterian/St Luke's Medical Center, Denver, CO; Colorado Blood Cancer Institute, Denver, CO","institution_ids":["https://openalex.org/I4210134093","https://openalex.org/I4210146389"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108220619","display_name":"Estil A. Vance","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Estil A. Vance","raw_affiliation_strings":["Sarah Cannon and Texas Oncology Transplant and Cellular Therapy Network, Medical City Dallas, Dallas, Texas","Sarah Cannon and Texas Oncology Transplant and Cellular Therapy Program at Medical City Dallas, Dallas, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sarah Cannon and Texas Oncology Transplant and Cellular Therapy Network, Medical City Dallas, Dallas, Texas","institution_ids":[]},{"raw_affiliation_string":"Sarah Cannon and Texas Oncology Transplant and Cellular Therapy Program at Medical City Dallas, Dallas, TX","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059637384","display_name":"Behyar Zoghi","orcid":"https://orcid.org/0000-0002-1650-7805","observed_orcids":["https://orcid.org/0000-0002-1650-7805"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Behyar Zoghi","raw_affiliation_strings":["Sarah Cannon and Texas Oncology Transplant and Cellular Therapy Network, Medical City Dallas, Dallas, Texas","Sarah Cannon Transplant and Cellular Therapy Program at Methodist Hospital, San Antonio, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sarah Cannon and Texas Oncology Transplant and Cellular Therapy Network, Medical City Dallas, Dallas, Texas","institution_ids":[]},{"raw_affiliation_string":"Sarah Cannon Transplant and Cellular Therapy Program at Methodist Hospital, San Antonio, TX","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5074515375","display_name":"Minoo Battiwalla","orcid":"https://orcid.org/0000-0001-6440-1899","observed_orcids":["https://orcid.org/0000-0001-6440-1899"]},"institutions":[{"id":"https://openalex.org/I4210088104","display_name":"Centennial Medical Center","ror":"https://ror.org/001be0c19","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210088104"]},{"id":"https://openalex.org/I4210100810","display_name":"Sarah Cannon","ror":"https://ror.org/014t21j89","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100810"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Minoo Battiwalla","raw_affiliation_strings":["Sarah Cannon Transplant and Cellular Therapy Network, TriStar Centennial Medical Center, Nashville, Tennessee","Sarah Cannon Transplant and Cellular Therapy Network, Nashville, TN; Sarah Cannon Transplant and Cellular Therapy Program at TriStar Centennial Medical Center, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sarah Cannon Transplant and Cellular Therapy Network, TriStar Centennial Medical Center, Nashville, Tennessee","institution_ids":["https://openalex.org/I4210088104","https://openalex.org/I4210100810"]},{"raw_affiliation_string":"Sarah Cannon Transplant and Cellular Therapy Network, Nashville, TN; Sarah Cannon Transplant and Cellular Therapy Program at TriStar Centennial Medical Center, Nashville, TN","institution_ids":["https://openalex.org/I4210088104","https://openalex.org/I4210100810"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5111754409"],"corresponding_institution_ids":["https://openalex.org/I4210120128"],"apc_list":{"value":3650,"currency":"USD","value_usd":3650},"apc_paid":{"value":3650,"currency":"USD","value_usd":3650},"fwci":3.0423,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":{"value":0.92394294,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":99},"biblio":{"volume":"31","issue":"8","first_page":"549.e1","last_page":"549.e11"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bendamustine","display_name":"bendamustine","score":0.9729999899864197},{"id":"https://openalex.org/keywords/fludarabine-and-cyclophosphamide","display_name":"fludarabine and cyclophosphamide","score":0.9549999833106995},{"id":"https://openalex.org/keywords/lymphodepletion","display_name":"lymphocyte depletion","score":0.7400000095367432},{"id":"https://openalex.org/keywords/car-t-cell-therapy","display_name":"CAR T-cell therapy","score":0.9129999876022339},{"id":"https://openalex.org/keywords/relapsed-refractory-non-hodgkin-lymphoma","display_name":"relapsed/refractory non-Hodgkin lymphoma","score":0.9509999752044678},{"id":"https://openalex.org/keywords/cytokine-release-syndrome","display_name":"cytokine release syndrome","score":0.8489999771118164},{"id":"https://openalex.org/keywords/immune-effector-cell-associated-neurotoxicity-syndrome","display_name":"immune effector cell-associated neurotoxicity syndrome","score":0.8109999895095825},{"id":"https://openalex.org/keywords/hematological-toxicity","display_name":"hematologic toxicity","score":0.7789999842643738},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.6700000166893005},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9539999961853027},{"id":"https://openalex.org/keywords/healthcare-resource-utilization","display_name":"healthcare resource utilization","score":0.7599999904632568},{"id":"https://openalex.org/keywords/outpatient-chemotherapy","display_name":"outpatient chemotherapy","score":0.33799999952316284}],"concepts":[{"id":"https://openalex.org/C2779263901","wikidata":"https://www.wikidata.org/wiki/Q185916","display_name":"Fludarabine","level":4,"score":0.8140496015548706},{"id":"https://openalex.org/C2781442060","wikidata":"https://www.wikidata.org/wiki/Q425745","display_name":"Bendamustine","level":4,"score":0.6941123604774475},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.6422072052955627},{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.5910722017288208},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.5487769246101379},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5475739240646362},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4455980956554413},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.28562331199645996},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.26667457818984985},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.15545958280563354},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.14571833610534668},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.08028268814086914}],"mesh":[{"descriptor_ui":"D000069461","descriptor_name":"Bendamustine Hydrochloride","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000069461","descriptor_name":"Bendamustine Hydrochloride","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000076962","descriptor_name":"Receptors, Chimeric Antigen","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008212","descriptor_name":"Lymphocyte Depletion","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D008228","descriptor_name":"Lymphoma, Non-Hodgkin","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014740","descriptor_name":"Vidarabine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D014740","descriptor_name":"Vidarabine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016219","descriptor_name":"Immunotherapy, Adoptive","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.jtct.2025.03.012","doi":"https://doi.org/10.1016/j.jtct.2025.03.012","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jtct.2025.03.012","pdf_url":null,"source":{"id":"https://openalex.org/S59987174","display_name":"Transplantation and Cellular Therapy","issn_l":"1083-8791","issn":["1083-8791","1523-6536","2666-6367"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Transplantation and Cellular Therapy","raw_type":"journal-article"},{"id":"pmid:40122282","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/40122282","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Transplantation and cellular therapy","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/j.jtct.2025.03.012","doi":"https://doi.org/10.1016/j.jtct.2025.03.012","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jtct.2025.03.012","pdf_url":null,"source":{"id":"https://openalex.org/S59987174","display_name":"Transplantation and Cellular Therapy","issn_l":"1083-8791","issn":["1083-8791","1523-6536","2666-6367"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Transplantation and Cellular Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320316754","display_name":"HCA Healthcare","ror":"https://ror.org/0237c2m81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W1996320020","https://openalex.org/W2067650601","https://openalex.org/W2124373740","https://openalex.org/W2151246207","https://openalex.org/W2407774696","https://openalex.org/W2601323577","https://openalex.org/W2773804840","https://openalex.org/W2788846482","https://openalex.org/W2797443945","https://openalex.org/W2903062212","https://openalex.org/W2905654445","https://openalex.org/W3082855561","https://openalex.org/W3213219566","https://openalex.org/W3214257916","https://openalex.org/W4200201081","https://openalex.org/W4281660952","https://openalex.org/W4290052566","https://openalex.org/W4310161921","https://openalex.org/W4319457643","https://openalex.org/W4386437862","https://openalex.org/W4387603348","https://openalex.org/W4389943594","https://openalex.org/W4391602012","https://openalex.org/W4391607735","https://openalex.org/W4392881874","https://openalex.org/W4395007321","https://openalex.org/W4400260890"],"related_works":["https://openalex.org/W4389243630","https://openalex.org/W4389246675","https://openalex.org/W7127266953","https://openalex.org/W7159610247","https://openalex.org/W4417017553","https://openalex.org/W7165736100","https://openalex.org/W7127272656","https://openalex.org/W4405096101","https://openalex.org/W4389220308","https://openalex.org/W4405044787"],"abstract_inverted_index":{"BACKGROUND:":[0],"Chimeric":[1],"antigen":[2],"receptor":[3],"T-cell":[4],"(CAR-T)":[5],"therapy":[6,297],"represents":[7],"a":[8,29,40,45,260,287],"transformative":[9],"advance":[10],"in":[11,63,86,108,193,241,279,298,323],"treating":[12],"relapsed/refractory":[13,89,299],"non-Hodgkin":[14],"lymphomas":[15],"(NHLs).":[16],"Effective":[17],"pre-infusion":[18],"lymphodepleting":[19],"chemotherapy":[20],"(LDC)":[21],"is":[22,286],"essential":[23],"for":[24,47,168,186,205,209,249,292,317],"optimizing":[25],"CAR-T":[26,92,123,169,187,280,296],"outcomes.":[27],"Traditionally,":[28],"combination":[30],"of":[31,57,69,79,243,263],"fludarabine":[32,42],"and":[33,55,77,151,158,176,211,220,270,306,315,335],"cyclophosphamide":[34],"(Flu/Cy)":[35],"has":[36],"been":[37],"used;":[38],"however,":[39],"global":[41],"shortage":[43],"warranted":[44],"search":[46],"alternative":[48,289],"regimens.":[49],"This":[50,113],"study":[51,71],"compares":[52],"the":[53,75],"efficacy":[54,76,305],"safety":[56,78],"bendamustine":[58,80,97,206,244],"versus":[59,81,207,215],"Flu/Cy":[60,82,103,250,291],"as":[61,83,259,301],"LDC":[62,84,181,293,338],"NHL":[64,90,118],"patients.":[65],"OBJECTIVES:":[66],"The":[67],"purpose":[68],"this":[70],"was":[72,203,213,226],"to":[73,102,128,166,247,290,295,331],"compare":[74],"regimens":[85,182],"patients":[87,119,185],"with":[88,121,189,228],"undergoing":[91],"therapy.":[93],"We":[94],"hypothesized":[95],"that":[96],"would":[98],"offer":[99],"comparable":[100,304],"outcomes":[101,334],"while":[104],"providing":[105],"logistical":[106],"advantages":[107],"outpatient":[109,318],"settings.":[110,326],"STUDY":[111],"DESIGN:":[112],"retrospective":[114],"analysis":[115,157,255],"evaluated":[116],"265":[117],"treated":[120],"FDA-approved":[122],"products":[124],"from":[125],"January":[126],"2018":[127],"October":[129],"2023.":[130],"Outcomes":[131],"included":[132],"cytokine":[133],"release":[134],"syndrome":[135,141],"(CRS),":[136],"immune":[137],"effector":[138],"cell-associated":[139],"neurotoxicity":[140],"(ICANS),":[142],"hematologic":[143,231],"recovery,":[144],"progression-free":[145],"survival":[146,149,156],"(PFS),":[147],"overall":[148],"(OS),":[150],"healthcare":[152],"resource":[153],"utilization.":[154],"Kaplan-Meier":[155],"multivariable":[159],"Cox":[160],"proportional":[161],"hazards":[162],"models":[163],"were":[164],"employed":[165],"adjust":[167],"product":[170],"type,":[171],"infusion":[172,257],"year,":[173,201],"disease":[174],"subtype,":[175],"dexamethasone":[177],"prophylaxis.":[178],"RESULTS:":[179],"Both":[180],"effectively":[183],"prepared":[184],"therapy,":[188],"no":[190],"significant":[191,261],"differences":[192],"CRS,":[194],"ICANS,":[195],"OS,":[196],"or":[197],"PFS.":[198],"At":[199],"one":[200],"OS":[202,264],"71%":[204,242],"68%":[208,214],"Flu/Cy,":[210],"PFS":[212,271],"60%":[216],"(P":[217,251],"=":[218,222,268],".3":[219],"P":[221,267,274],".4,":[223],"respectively).":[224],"Bendamustine":[225,285],"associated":[227],"less":[229],"severe":[230],"toxicity;":[232],"ANC":[233],"levels":[234],"did":[235],"not":[236],"fall":[237],"below":[238],"0.5":[239],"K/\u00b5L":[240],"recipients":[245],"compared":[246],"17%":[248],"<":[252,275],".001).":[253],"Multivariable":[254],"identified":[256],"year":[258],"predictor":[262],"(HR":[265,272],"0.77,":[266],".008)":[269],"2.6,":[273],".001),":[276],"reflecting":[277],"improvements":[278],"practices":[281],"over":[282],"time.":[283],"CONCLUSION:":[284],"viable":[288],"prior":[294],"NHL,":[300],"it":[302],"demonstrates":[303],"safety.":[307],"Its":[308],"operational":[309],"advantages,":[310],"including":[311],"reduced":[312],"hospitalization":[313],"rates":[314],"suitability":[316],"administration,":[319],"underscore":[320],"its":[321],"potential":[322],"diverse":[324],"clinical":[325],"Prospective":[327],"studies":[328],"are":[329],"needed":[330],"confirm":[332],"long-term":[333],"further":[336],"optimize":[337],"strategies.":[339]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2025-03-23T00:00:00"}